Labcorp Holdings Inc. (LH) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $268.87. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LH = $367.74 (+36.8% from the current price, the stock appears undervalued). Analyst consensus target is LH = $321 (+19.5% upside).
Valuation: LH trades at a trailing Price-to-Earnings (P/E) of 25.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.09.
Financials: revenue is $14.0B, -1.3%/yr average growth. Net income is $877M, growing at +9.5%/yr. Net profit margin is 6.3% (thin). Gross margin is 26.8% (-2.7 pp trend).
Balance sheet: total debt is $7.2B against $8.6B equity (Debt-to-Equity (D/E) ratio 0.84, moderate). Current ratio is 1.42 (adequate). Debt-to-assets is 39.2%. Total assets: $18.4B.
Analyst outlook: 26 / 35 analysts rate LH as buy (74%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 36/100 (Fail), Growth 40/100 (Partial), Past 100/100 (Pass), Health 50/100 (Partial), Moat 54/100 (Partial), Future 79/100 (Pass), Income 45/100 (Partial).
